Biotechnology funds — compare 21 funds on fees and returns

Morningstar category: Sector Equity Biotechnology

Funds that invest in biotechnology companies developing new medicines and treatments. Much depends on individual trials and approvals, so risk is high.

How good is this fund, really?

PowerFunds rates every fund against the rest of its category and warns you when one falls behind. See this fund's rating and watch it for free.

See which are best
Rating
ARK Genomic Revolution ETF A USD Acc ETF – +80%––
AXA Framlington Biotech Fund - Z Acc Actively managed fund 0.82% +8%+12%+6%
AXA Framlington Biotech Z Inc Actively managed fund 0.82% +8%+12%+6%
Biotech Growth Ord Investment trust – +17%+25%+3%
Candriam Eqs L Biotech I GBP Cap Actively managed fund – +25%+23%+12%
Candriam Eqs L Biotech R GBP Cap Actively managed fund – +25%+23%+13%
First Trust NYSE Arca Biotech ETFAUSDAcc ETF – +47%+28%+11%
Franklin Biotechnology Discv Z(acc)GBP Actively managed fund – +20%+25%+11%
Global X Genomics & Biotech ETF USD Acc ETF – +63%+27%–
International Biotechnology Ord Investment trust 1.27% +21%+28%+12%
Invesco NASDAQ Biotech ETF ETF – +36%+26%+8%
iShares Nasdaq US Biotech ETF USD Acc ETF – +37%+26%+8%
iShares Nasdaq US Biotech ETF USD Dist ETF – +37%+26%+8%
Janus Henderson Hrzn Biotec H2 USD Actively managed fund – +21%+30%+14%
JPM Thmtcs Gentc Thrps C dist GBP Actively managed fund – +27%+14%−2%
L&G Pharma Breakthrough ETF ETF – +15%+17%+3%
LS ARK Genomic Revolution Trkr ETP Scs Actively managed fund – –––
Pictet-Biotech I dy GBP Actively managed fund 1.1% +24%+26%+11%
Polar Capital Biotech I Inc Actively managed fund – –––
RTW Biotech Opportunities Ord Investment trust – +27%+19%+9%
WisdomTree BioRevolution ETF - USD Acc ETF – +49%+25%–

Tap a column heading to sort. Annualised return. 3 and 5 years are averages per year. Past performance is no guarantee of future results.